< Back to previous page
Researcher
Steven Goossens
- Keywords:In vitro models, cell biology, in vivo animal models, mouse model, translational research, leukemia, Metastasis
- Disciplines:Hematology, Cancer biology, Cancer therapy
Affiliations
- Department of Diagnostic Sciences (Department)
Member
From1 Oct 2019 → Today - Department of Biomolecular Medicine (Department)
Member
From1 Oct 2018 → 30 Sep 2019 - Department of Pediatrics and medical genetics (Department)
Member
From1 Oct 2016 → 30 Sep 2018 - Department of Biomedical molecular biology (Department)
Member
From1 Feb 2000 → 30 Sep 2019
Infrastructure
1 - 1 of 1
- Patient Derived Xenograft Platform Ghent (Consortium coordinator)
Projects
1 - 10 of 22
- Facility : Patiënt-afgeleide xenograft modellen – UGent;From1 Feb 2024 → TodayFunding: BOF - research organisations
- Establishing safety and efficacy of an improved Asparaginase in dog models: final preparation for Phase I clinical trialFrom1 Jan 2024 → TodayFunding: Nonprofit institution or equivalents
- Towards clinical testing of novel stabilized less toxic asparaginases for the treatment of acute lymphoblastic leukemiaFrom20 Dec 2023 → TodayFunding: IOF - technology validation in lab
- Targeting the amino acid stress response (AAR) pathway to treat triple negative breast cancersFrom1 Oct 2023 → TodayFunding: Nonprofit institution or equivalents
- Towards clinical testing of improved, less toxic and less immunogenic, L-asparaginase preparations for the treatment of acute lymphoblastic leukemiaFrom1 Oct 2023 → TodayFunding: BOF - postdoctoral mandates
- Oncogenic Role of SOX11 in T-cell acute lymphoblastic leukemiaFrom1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Preclinical validation of a less toxic variant for paediatric leukemiaFrom1 Oct 2022 → 30 Sep 2023Funding: Nonprofit institution or equivalents
- A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapiesFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Replication fork protector dependency factors: novel targets for combination treatment and immunomodulation in neuroblastoma (REINFORCE)From1 Jan 2022 → TodayFunding: BOF - projects
- Targeting MEF2C in immature acute leukemiasFrom1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)